Tetracyline compounds
US10315992B2 · kind B2 · utility
4Cited by
43References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 6, 2017 |
| Grant date | Jun 11, 2019 |
| Priority date | — |
| Expiry date | Jan 6, 2037 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof. The variables for Structural Formula (I) are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula (I), or a pharmaceutically acceptable salt thereof, and its therapeutic use.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.